Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Detailed price information for Dr. Reddy's Laboratories Ltd ADR (RDY-N) from The Globe and Mail including charting and trades.

Hyderabad: Dr. Reddy's Laboratories is gearing up to shake up the global weight-loss drug market with the launch of an ...

Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...

Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Reddy's Laboratories has kicked off FY26 with double-digit growth. M.V. Ramana, CEO of Branded Markets (India & Emerging ...

SKLTSHU Vice Chancellor Dr Danda Rajireddy said a plan is being made to provide affordable, quality seeds to horticulture farmers. The initiative aims to boost yields with seeds resistant to climate ...

Speakers at the “Dr. Neelam Sanjiva Reddy Memorial Awards-2025” hailed him as a beacon of hope for the current and future ...

The Nifty Pharma index ended Friday on a positive note, advancing 0.54%. Top gainers included Cipla Ltd and Torrent Pharmaceuticals Ltd, while Natco Pharma Ltd led the losses.

India VIX, the barometer to assess market anxiety, flared up over 5 percent to reflect heightened market volatility.

On the NSE, 14 out of the 15 sectors ended in the red, with the Nifty Media, Energy, Defence and Oil & Gas declining the most ...

Cipla , India's third-largest drugmaker by sales, reported a better-than-expected quarterly profit on Friday, driven by higher domestic demand for its generic respiratory drugs.